MORGAN STANLEY PLC/CALL/ELI LILLY & CO/430/0.01/20.09.24 | Market Closed - Börse Stuttgart 19:30:28 28/06/2024 BST | ||
| 4.57 EUR | +1.56% |
|
| Current month | +24.18% | ||
| 1 month | +27.65% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ELI LILLY AND COMPANY
Latest news about ELI LILLY AND COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 28/06/24 | 4.57 | +1.56% |
| 27/06/24 | 4.5 | -0.44% |
| 26/06/24 | 4.52 | +0.67% |
| 25/06/24 | 4.49 | +1.13% |
| 24/06/24 | 4.44 | +2.54% |
Delayed Quote Börse Stuttgart
Last update June 28, 2024 at 07:30 pm
More quotesStatic data
| Product type | Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | ELI LILLY AND COMPANY |
| Issuer | Morgan Stanley |
| WKN | MB4QTK |
| ISIN | DE000MB4QTK9 |
| Date issued | 22/03/2023 |
| Strike | 430 $ |
| Maturity | 20/09/2024 (83 Days) |
| Parity | 100 : 1 |
| Emission price | 0.28 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 4.57 € |
|---|---|
| Lowest since issue | 0.225 € |
| Delta | 0.97x |
| Omega | 1.812 |
| Premium | 1.02x |
| Gearing | 1.87x |
| Moneyness | 2.106 |
| Difference Strike | -475.4 $ |
| Difference Strike % | -110.55% |
| Spread | 0.01 € |
| Spread % | 0.22% |
| Theoretical value | 4.525 |
| Implied Volatility | 94.00 % |
| Total Loss Probability | 7.358 % |
| Intrinsic value | 4.439 |
| Present value | 0.0865 |
| Break even | 914.64 € |
| Theta | -0.01x |
| Vega | 0x |
| Rho | 0.01x |
Company Profile
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (19.5%);
- immunology diseases (11.1%);
- neurology (8.4%): primarily drugs used in treating depression and schizophrenia;
- other (3.3%).
Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
Consensus: Eli Lilly and Company
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
905.4
USD
Average target price
868.9
USD
Spread / Average Target
-4.03%
- Stock Market
- Warrants
- Warrant
